The effect of anticonvulsant therapy on early morning concentration of cortisol in saliva and plasma was assessed in a group of epileptic patients receiving regular phenytoin medication and the results compared with those obtained from a group of normal subjects not receiving drug therapy. Values of cortisol in matched samples of plasma (331 +/‐ 23 nmol l‐1, mean +/‐ s.e. mean, n = 6) and saliva (11.4 +/‐ 0.9 nmol l‐1, mean +/‐ s.e. mean, n = 9) provided by epileptics did not differ significantly from those in the plasma (334 +/‐ 41 nmol l‐1, mean +/‐ s.e. mean) and saliva (12.0 +/‐ 2.0 nmol‐1, mean +/‐ s.e. mean) of healthy volunteers (n = 12). Six anticonvulsant‐treated epileptics, together with six age and sex matched normal volunteers, each received intravenous dexamethasone (1 mg h‐1) to determine the half‐life of cortisol in plasma and saliva. In the anticonvulsant‐ treated group, the half‐life of cortisol in plasma (73 +/‐ 5 min, mean +/‐ s.e. mean) and saliva (83 +/‐ 5 min, mean +/‐ s.e. mean) was reduced significantly (P less than 0.01 plasma, P less than 0.05 saliva) from that observed in healthy volunteers. In patients, the half life of cortisol and antipyrine showed a significant correlation (r2 = 0.75, P less than 0.05 plasma, r2 = 0.71, P less than 0.05 saliva). The antipyrine half‐life in saliva was reduced significantly (P less than 0.02) and the antipyrine clearance rate, increased significantly (P less than 0.005) in the treated epileptic group, reflecting drug‐ induced microsomal enzyme production.(ABSTRACT TRUNCATED AT 250 WORDS)